A Phase I/Ii Trial of BNC105P With Everolimus in Metastatic Renal Cell Carcinoma

Clinical Cancer Research- United States

doi 10.1158/1078-0432.ccr-14-3370

Full Text

Abstract

Available in

Date

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2015English

Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma

Urology
Urology
2008English

The Effect of Everolimus and Low-Dose Cyclophosphamide on Immune Cell Subsets in Patients With Metastatic Renal Cell Carcinoma: Results From a Phase I Clinical Trial

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Recombinant Human Interleukin 6 in Metastatic Renal Cell Cancer: A Phase II Trial

British Journal of Cancer
Cancer ResearchOncology
1996English

Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial

Oncologist
Cancer ResearchMedicineOncology
2019English

A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients With Metastatic Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Everolimus in Metastatic Renal Cell Carcinoma : Preliminary Experience From Chang Gung Memorial Hospital

Biomedical Journal
Medicine
2012English

Phase II Trial of Fenretinide in Advanced Renal Carcinoma

Investigational New Drugs
OncologyPharmacology
2005English

Perioperative Immunomodulation With Interleukin-2 in Patients With Renal Cell Carcinoma: Results of a Controlled Phase II Trial

British Journal of Cancer
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy